Bosh sahifaPLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
2,18 $
Seans yopilganidan keyin:(1,30%)-0,028
2,15 $
Yopilgan:14-yan, 19:45:23 (GMT-5) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
2,20 $
Kunlik diapazon
2,11 $ - 2,23 $
Yillik diapazon
0,82 $ - 2,36 $
Bozor kapitalizatsiyasi
160,52 mln USD
Oʻrtacha hajm
492,86 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 17,96 mln | 73,60% |
Joriy xarajat | 5,59 mln | -23,79% |
Sof foyda | 3,24 mln | 274,73% |
Sof foyda marjasi | 18,02 | 200,67% |
Har bir ulushga tushum | — | — |
EBITDA | 4,32 mln | 373,07% |
Amaldagi soliq stavkasi | 15,79% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 27,41 mln | -33,11% |
Jami aktivlari | 61,56 mln | -29,70% |
Jami passivlari | 29,13 mln | -40,95% |
Umumiy kapital | 32,44 mln | — |
Tarqatilgan aksiyalar | 73,63 mln | — |
Narxi/balansdagi bahosi | 5,00 | — |
Aktivlardan daromad | 13,03% | — |
Kapitaldan daromad | 21,49% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 3,24 mln | 274,73% |
Operatsiyalardan naqd pul | 4,10 mln | 159,60% |
Sarmoyadan naqd pul | 20,33 mln | 197,36% |
Moliyadan naqd pul | -20,42 mln | — |
Naqd pulning sof oʻzgarishi | 4,01 mln | 114,44% |
Boʻsh pul | 1,05 mln | 113,52% |
Haqida
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Tashkil etilgan
1993
Bosh ofis
Sayt
Xodimlar soni
208
